Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tumor Size Matters—Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy

Cancers(2020)10.3390/cancers12030714Source: DataRank Database

Tumor Size Matters—Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy is a research paper published in Cancers (2020). On theSindex it has a DataRank of 0. It has been cited 30 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access30 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: goldTopics (16)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Mi-Heon Lee ORCID,Christine Nguyen ORCID,Anusha Kalbasi ORCID,James Sayre ORCID,Tahmineh Romero ORCID

Live enrichment

PubMed:32197352 PMC:PMC7140082

UCLA’s CTSI KL2 Award

Grant: to Anusha Kablas

Cancer Foundation Luxembourg

Grant: to Jean Philippe Nesseler

SARC Career Enhancement Program

Grant: to Anusha Kalbasi

National Institutes of Health

Grant: 5R01CA191234-05

Radiotherapy-induced tumor immunity

National Institutes of Health

Grant: 1R01CA226875-01

NCI NIH HHS

Grant: R01 CA191234

NCI NIH HHS

Grant: P30 CA016042

NCI NIH HHS

Grant: R01 CA226875

National Institutes of Health

Grant: 1R01CA226875-01A1

Myeloid reprogramming in response to acute radiation tissue damage

goldLicense: cc-by

publisherhttps://www.mdpi.com/2072-6694/12/3/714/pdf?version=1584522771

publisherhttps://www.mdpi.com/2072-6694/12/3/714/pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7140082

repositoryhttps://doaj.org/article/ebecdd9f900445cc8236a92072eb1da9

repositoryhttps://escholarship.org/uc/item/7b31m16z

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicine

Keywords

FibrosarcomaTumor SizeRadiation TherapyProgrammed Cell Death Protein 1Biomedical and Clinical SciencesOncology and CarcinogenesisImmunology610ArticleRadiation OncologyImmunizationImmunotherapyCancer

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of Spatial mapping of tumor heterogeneity in whole-body PET–CT: a feasibility study

10.6084/m9.figshare.24634522.v1figshare

Additional file 1 of Spatial mapping of tumor heterogeneity in whole-body PET–CT: a feasibility study

10.6084/m9.figshare.24634522figshare

Additional file 2 of Spatial mapping of tumor heterogeneity in whole-body PET–CT: a feasibility study

10.6084/m9.figshare.24634566.v1figshare

Additional file 2 of Spatial mapping of tumor heterogeneity in whole-body PET–CT: a feasibility study

10.6084/m9.figshare.24634566figshare

Tumor Size Matters—Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy

FAIR Checklist

Authors (9)

Funding (9 grants)

Open Access

Topics

Linked Datasets (4)

Annotations (Europe PMC)